4 research outputs found

    Роль ΠΏΠΎΠ»ΠΈΠΌΠΎΡ€Ρ„ΠΈΠ·ΠΌΠ° Π‘677Π’ Π³Π΅Π½Π° MTHFR Π² Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠΈ ослоТнСнного тСчСния Π˜Π‘Π‘ ΠΈ гипСртоничСской Π±ΠΎΠ»Π΅Π·Π½ΠΈ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с дислипидСмиями

    Get PDF
    The present study was designed to determine the possibility of the application the genotyping of the patients with dislipidaemia as an additional factor for the prediction of the cardiovascular complications. The distribution of the polymorphism C677T of the gene MTHFR among the 62 patients with dislipidaemia was studied. Allele-specific PCR was applied for detection the C677T mutation/ These results provide the genetic evidence that 677T allele of the gene MTHFR correlates with the development of the complications of the coronary heart disease for the patients with dislipidaemia (p = 0,01). It was demonstrated that more complex and durable antihypertension and cardiotropic therapy must be applicated for the carries of the 677T allele among the dislipidaemia patients. These data indicate the appreciable role C677T polymorphism of MTHFR for the decreasing of the cardiovascular complications among the patients with dislipidaemia and for detection the complexity and longevity of the medical treatments.Π Π°Π±ΠΎΡ‚Π° ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»Π°ΡΡŒ с Ρ†Π΅Π»ΡŒΡŽ ΠΎΡ†Π΅Π½ΠΊΠΈ прогностичСской значимости ΠΏΠΎΠ»ΠΈΠΌΠΎΡ€Ρ„ΠΈΠ·ΠΌΠ° Π‘677Π’ Π³Π΅Π½Π° ΠΌΠ΅Ρ‚ΠΈΠ»Π΅Π½Ρ‚Π΅Ρ‚Ρ€Π°Π³ΠΈΠ΄Ρ€ΠΎΡ„ΠΎΠ»Π°Ρ‚Ρ€Π΅Π΄ΡƒΠΊΡ‚Π°Π·Ρ‹ (MTHFR) Π² Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠΈ ослоТнСнного тСчСния Π˜Π‘Π‘ ΠΈ гипСртоничСской Π±ΠΎΠ»Π΅Π·Π½ΠΈ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с дислипидСмиями. Для выявлСния ΠΌΡƒΡ‚Π°Ρ†ΠΈΠΈ Π‘677Π’ использовали аллСль-спСцифичСскиС ПЦР. Π‘Ρ‹Π»Π° выявлСна коррСляционная Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡ‚ΡŒ ΠΌΠ΅ΠΆΠ΄Ρƒ Π½ΠΎΡΠΈΡ‚Π΅Π»ΡŒΡΡ‚Π²ΠΎΠΌ ΠΌΡƒΡ‚Π°Π½Ρ‚Π½ΠΎΠ³ΠΎ аллСля 677Π’ ΠΈ частой развития Π˜Π‘Π‘ Π² исслСдуСмой Π³Ρ€ΡƒΠΏΠΏΠ΅ Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… (Ρ€ = 0,01). Для ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с дислипидСмиями Π½Π΅ выявлСно Π·Π½Π°Ρ‡ΠΈΠΌΠΎΠΉ коррСляции ΠΌΠ΅ΠΆΠ΄Ρƒ Π½ΠΎΡΠΈΡ‚Π΅Π»ΡŒΡΡ‚Π²ΠΎΠΌ ΠΌΡƒΡ‚Π°Π½Ρ‚Π½ΠΎΠ³ΠΎ аллСля 677Π’ Π³Π΅Π½Π° MTHFR ΠΈ частотой возникновСния ΠΈ ΠΈΠ½Ρ‚Π΅Π½ΡΠΈΠ²Π½ΠΎΡΡ‚ΡŒΡŽ развития гипСртоничСской Π±ΠΎΠ»Π΅Π·Π½ΠΈ (Ρ€ = 0,8). ΠŸΠΎΠ»ΡƒΡ‡Π΅Π½Π½Ρ‹Π΅ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ ΠΈΠΌΠ΅ΡŽΡ‚ сущСствСнноС Π·Π½Π°Ρ‡Π΅Π½ΠΈΠ΅ для сниТСния риска ослоТнСнного ΠΈ Π½Π΅ΡΡ‚Π°Π±ΠΈΠ»ΡŒΠ½ΠΎΠ³ΠΎ тСчСния сСрдСчно-сосудистых Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с дислипидСмиями, Π° Ρ‚Π°ΠΊΠΆΠ΅ для Π²Ρ‹Π±ΠΎΡ€Π° объСма ΠΈ ΠΏΡ€ΠΎΠ΄ΠΎΠ»ΠΆΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΠΈ ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠΌΠΎΠΉ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ ΠΈ цСлСсообразности примСнСния гиполипидСмичСских срСдств

    Arterial hypertension and coronary heart diseases development in patients with dyslipoproteinemia against polymorphisms of gp iiia genes and prothrombin gene

    No full text
    The cause of a genetic predisposition to a variety of diseases, including coronary atherosclerosis and coronary heart disease is the presence of defective integrin receptors on the cell surfaces, as well as thrombophilia associated also with prothrombin gene mutations. This paper deals with the study of frequency of alleles of one of the integrins, GPIIIa glycoprotein (Ξ²- type III subunit), and prothrombin gene in patients with dyslipidemia. We have established that the presence of allele PLA2 of GPIIIa gene and allele G20210A of prothrombin gene in the genotype of a patient is a genetic risk factor for intensive development of coronary heart disease and hypertension in patients with dyslipidemia, which is associated with a higher incidence of complications and the need for carrying out more comprehensive antihypertensive therapy to stabilize blood pressure

    Arterial hypertension and coronary heart diseases development in patients with dyslipoproteinemia against polymorphisms of gp iiia genes and prothrombin gene

    No full text
    The cause of a genetic predisposition to a variety of diseases, including coronary atherosclerosis and coronary heart disease is the presence of defective integrin receptors on the cell surfaces, as well as thrombophilia associated also with prothrombin gene mutations. This paper deals with the study of frequency of alleles of one of the integrins, GPIIIa glycoprotein (Ξ²- type III subunit), and prothrombin gene in patients with dyslipidemia. We have established that the presence of allele PLA2 of GPIIIa gene and allele G20210A of prothrombin gene in the genotype of a patient is a genetic risk factor for intensive development of coronary heart disease and hypertension in patients with dyslipidemia, which is associated with a higher incidence of complications and the need for carrying out more comprehensive antihypertensive therapy to stabilize blood pressure
    corecore